Introduction
Surgical site infections (SSIs) are the third most common healthcare-associated infections (HCAIs) and are associated with excess length of stay, hospital costs and mortality [1] [2] [3] . The national SSI surveillance system in England operated by Public Health England (PHE) has captured data on microorganisms reported as causing SSI since 1997, but evidence for trends in aetiology as observed in bacteraemias captured separately by PHE have not been comprehensively assessed [4] [5] [6] .
Data captured by PHE's voluntary surveillance of laboratory isolates in England and Wales showed that bacteraemia due to methicillin-resistant S. aureus (MRSA) increased sharply from 1990 to 2003 [7] . Progress in the control of HCAIs was subject to scrutiny by England's National Audit Office in surveillance. The DoH also introduced targeted infection control policies to standardise and improve practices around the prevention of MRSA which included MRSA screening and decolonisation, care of invasive devices and hand hygiene [5;7;8] . 4 The emergence of E.coli infections has also caused concern. Using PHE's voluntary laboratory surveillance data, E. coli reported as causing bacteraemia in England increased by 33% between 2004 and 2008 [6] .
For this study, SSI micro-organism data captured by PHE's national SSI surveillance provided an opportunity to ascertain whether similar trends to those observed in bacteraemia were also present in SSIs.
Materials and methods

Case ascertainment and data collection process
The data for this study were captured by the national SSI surveillance system (SSISS). This programme was established in 1997 by the Public Health Laboratory Service, now PHE to provide a benchmarking service and to enable hospitals to use data to improve practice. Initially participation was voluntary but since 2004, all NHS hospitals have been mandated to undertake a minimum of three months surveillance each year in orthopaedic surgery. An additional 13 categories of surgical procedure are offered for voluntary national surveillance [14;15] . Thus the surveillance dataset comprises orthopaedic surgical procedures collected annually by most hospitals and other surgical categories collected on an intermittent basis by some hospitals. All participating hospitals are trained by PHE in using the standard case definitions for superficial, deep or organ-space SSIs based on internationally recognised criteria with minor modifications in the English protocol [15] . In England the presence of pus cells is additionally required for microbiological confirmation and for superficial SSIs, a clinician diagnosis must accompany two clinical signs and symptoms. All eligible patients are followed up on a prospective basis to identify SSIs within 30 days of surgery for superficial SSIs or non-implant procedures. For procedures with an implant, an SSI can be reported for up to one year.
Data validation is undertaken to correct errors and from 2004 has been handled automatically via the web-based application. Participating hospitals can voluntarily report up to three clinically significant isolates using a standard set of codes denoting species, genus, or a generic group e.g. 'coliforms'.
Antimicrobial susceptibility data are collected for S. aureus. S. aureus can be reported as methicillinsensitive, methicillin-resistant or vancomycin-intermediate (VISA). Methicillin-resistant S,aureus is inclusive of VISA. Data on surgical antimicrobial prophylaxis agents are not collected.
Inclusion criteria
Data on causative organism from SSI cases detected during the inpatient stay between 1 January 2000 and 31 December 2013 were included. Data from non-NHS hospitals were excluded. The data covered 13 defined surgical categories. SSIs diagnosed on readmission were excluded as readmission surveillance did not become mandatory until 2008. Given the nature of our study (examining long-term trends in the microbial aetiology of SSIs), we wanted to exclude a potential source bias deriving from the mandatory readmission surveillance introduced part way through our study period.
Statistical analysis
This study was based on an analysis of cases of SSI. All pathogens reported as a causative organisms were included in the analysis. For analyses at genus or family level, monomicrobial and polymicrobial cases were combined provided the latter included species from the same genera or family.
Fixed and mixed effects models were fitted using Stata/SE 13.1 (StataCorp, TX). Standard logistic regression was used to analyse binary outcome data under a Bernoulli distribution. The mean annual change in the odds of SSI due to a pathogen was estimated using a linear predictor with seven confounding variables: age (continuous), patient sex, ASA score (pre-operative health status dichotomised into <3 and ≥3), wound class (dichotomised into clean/clean-contaminated and contaminated/dirty), duration of operation (dichotomised according to the 75 th percentile value rounded to the nearest hour), days of in-patient follow-up (continuous) and surgical category. For the surgical category predictor data from eight surgical categories were compressed into four groups to permit model maximisation: gastro-intestinal (large, small bowel and gastric), orthopaedic (total hip and knee prosthesis, hip hemiarthroplasty and reduction of long bone fracture), coronary artery bypass graft (CABG) and vascular surgery. The other five categories were excluded from the model because the annual volumes were small and they were unrelated to the four groups. As our dataset comprised inpatient-detected cases, we adjusted for variation in the length of follow-up during the inpatient stay.
The logistic linear mixed model added random hospital effects to take into account extra variation not explained by the confounding factors. The information criterion approach (AIC) was used to determine the relative optimum fit compared to the fixed effects model. Adjusted ORs, 95% CIs and p-values are reported. Enterbacteriaceae were observed among deep-organ-space SSIs (Table 2) .
Multi-variable analysis
For the analysis of trends in aetiology among cases of SSI, a total of 7,476 inpatient SSIs with microbiology data were available for the multivariable analysis based on eight surgical categories. The excluded SSIs (2,291/9,767) were due to the four surgical categories that could not be grouped with any of the nine categories and missing data on required covariates. The majority of the missing data related to ASA score (1,480/2,291).
After controlling for covariates, there was insufficient evidence to support an association between S. analysis. The majority of missing records were due to missing ASA score data (1,212/1,898). Changes in microbial aetiology in gastric surgery were not evaluated due to sparse data (<25 SSI cases per time period). The adjusted odds of SSIs due to MRSA decreased significantly between these two periods in all eight categories examined with the largest decrease observed in CABG surgery ( prosthesis as this showed a non-significant increase (data not shown).
We also examined the background trends in the odds of all-cause SSI based on all exposure data for each of the eight surgical categories also using the mixed model (not shown). The data comprised The decreasing prevalence of EMRSA-16, one of two dominant MRSA epidemic strains is of interest although these predate the national MRSA control measures [25] .The changing ecology of this strain however may have also had some influence in the reduction of MRSA SSIs and mandatory MRSA bacteraemia cases captured by PHE.
The increase in deep/organ-space SSI caused by CoNS between 2005 and 2013, although in this analysis missed statistical significance, was based on a small sample. CoNS are however indolent pathogens and infections frequently present too late to be captured by inpatient-based surveillance so are likely to be under-reported, hence the small sample size. It should be noted that our analysis by surgical category, though based on all SSI types indicated an increase in CoNS in orthopaedic and CABG surgery both of which include prosthetic material. Potential explanations for the increase include emerging resistance to agents used for prophylaxis such as glycopeptides and aminoglycosides both of which are used as surgical prophylaxis in orthopaedic surgery in some NHS Trusts [26] [27] [28] or sub-optimal skin decontamination due to reduced susceptibility of staphylococci to chlorhexidine [29] .
In the UK, there is, as yet, no specific evidence of any reduced susceptibility to chlorhexidine.
An earlier study based on PHE's voluntary laboratory-based surveillance data indicated that bacteraemia episodes due to E. coli and Klebsiella spp. increased by 33% and 14% respectively from 2004 to 2008 [6] . This is an important context for the SSI aetiology trends we observed in our study.
The [32;33] . Potentially lower levels might also occur in obese patients [34] than for agents used in the earlier part of our study period. In addition,
antibiotic-resistant Enterobacteriaceae may be refractory to the effects of some of the current prophylaxis regimens [35] due to the emergence of extended-spectrum β-lactamases and carbapenamase-producing Enterobacteriaceae reported internationally [36;37] . As we did not capture antibiotic susceptibility data on Gram-negative SSIs, we could not determine how much of the increase in Enterobacteriaceae SSIs was fuelled by antibiotic resistance. [38] . Data from the USA derived from two separate summaries for 2006/07 and 2009/10 showed that S. aureus remained stable at 30% of SSI isolates in both periods although MRSA decreased from 49% to 44% respectively. Although the proportion of SSI isolates due to E.coli or K. pneumoniae/K. oxytoca remained unchanged, an increase in cephalosporin-resistance was noted among E. coli isolates from 5% to 11% over these two periods [39;40] . Data from sentinel laboratories in the USA participating in CDC's bacterial surveillance network also showed reductions in MRSA; the modelled incidence of hospital-onset invasive MRSA significantly decreased 9 . 4%
annually from 2005 to 2008. The authors believed this reflected the dissemination of MRSA prevention practices in US hospitals [41] . However, as of 2011, CDIs remain high in the USA as well as the use of broad-spectrum antibiotics in acute hospitals [42;43] .
In England the decrease in MRSA as a reported cause of SSI may reflect the success of intensified MRSA control strategies and the impact of changes in antimicrobial prescribing, the latter reducing the propensity for MRSA selection. The increase in Enterobacteriaceae as reported causes of SSI however demands further study given the increasing antimicrobial resistance among these pathogens and the need to inform the selection of appropriate and effective antimicrobial prophylaxis.
Limitations
Since neither patient nor hospital-level data on hospital infection control interventions or surgical prophylaxis are collected, an inference is made between the timing of large-scale national policies and the trends in reported SSI pathogens Although ecological analyses are useful at population-level it is not possible to establish direct cause and effect.
An analysis of trends in the leading species of Enterobacteriaceae (E. coli and K. pneumonia) could not be undertaken due to the high proportion of organisms reported as "coliforms".
Although there was a gradual decline in the proportion of SSIs with causative organism data reported, there was no temporal relationship between tis decline and the observed microbial aetiology trends.
Some of the organisms reported for superficial SSIs and included in the main analysis may represent colonisation with regional flora. However, similar trends in aetiology were observed for deep/organspace SSIs where such contamination is much less likely.
Participation in the non-orthopaedic categories is voluntary resulting in lower hospital coverage compared to the mandatory orthopaedic categories, intermittent or no surveillance in any given year.
. Further study is needed to better understand these effects and to ensure that antimicrobial surgical prophylaxis is optimised.
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